/MDAI
MDAI Stock - Spectral AI, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.55-1.58%
$0.03 (-1.58%) • Jan 13
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+125.1%upside
Target: $3.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDAI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.54 – $1.57
TARGET (TP)$3.50
STOP LOSS$1.43
RISK/REWARD1:15.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$3.21
52W Low$1.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $29.58M | $18.06M | $25.37M | $15.24M |
| Gross Profit | $13.27M | $7.88M | $10.84M | $7.05M |
| Gross Margin | 44.9% | 43.6% | 42.7% | 46.3% |
| Operating Income | $-6,582,000 | $-12,984,000 | $-2,647,000 | $-4,179,000 |
| Net Income | $-15,315,000 | $-20,854,000 | $-2,912,000 | $-3,988,000 |
| Net Margin | -51.8% | -115.5% | -11.5% | -26.2% |
| EPS | $-0.85 | $-1.48 | $-0.16 | $-0.33 |
Company Overview
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$4
Average Target
↑ 157.2% Upside
Now
$4
Low
$4
Average
$4
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 23rd 2024 | BTIG Research | Initiation | Buy | $4 |
Earnings History & Surprises
MDAIBeat Rate
50%
Last 8 quarters
Avg Surprise
+33.3%
EPS vs Estimate
Beats / Misses
4/3
1 met exactly
Latest EPS
$-0.13
Q4 2025
EPS Surprise History
Q1 24
0.0%
$-0.22vs$-0.22
Q2 24
+26.9%
$-0.19vs$-0.26
Q3 24
-14.3%
$-0.16vs$-0.14
Q4 24
+85.7%
$-0.02vs$-0.14
Q1 25
+53.8%
$-0.06vs$-0.13
Q2 25
+210.0%
$0.11vs$-0.10
Q3 25
-42.9%
$-0.10vs$-0.07
Q4 25
-52.9%
$-0.13vs$-0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 26, 2026 | $-0.12 | — | — | — |
Q4 2025 | Nov 11, 2025 | $-0.09 | $-0.13 | -52.9% | ✗ MISS |
Q3 2025 | Aug 12, 2025 | $-0.07 | $-0.10 | -42.9% | ✗ MISS |
Q2 2025 | May 14, 2025 | $-0.10 | $0.11 | +210.0% | ✓ BEAT |
Q1 2025 | Mar 27, 2025 | $-0.13 | $-0.06 | +53.8% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-0.14 | $-0.02 | +85.7% | ✓ BEAT |
Q3 2024 | Aug 12, 2024 | $-0.14 | $-0.16 | -14.3% | ✗ MISS |
Q2 2024 | May 7, 2024 | $-0.26 | $-0.19 | +26.9% | ✓ BEAT |
Q1 2024 | Mar 27, 2024 | $-0.22 | $-0.22 | 0.0% | = MET |
Q4 2023 | Nov 13, 2023 | — | $-0.30 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.17 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.20 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.06 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 29, 2022 | — | $0.05 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.15 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.35 | — | — |
Latest News
BTIG Maintains Buy on Spectral AI, Lowers Price Target to $3
➖ NeutralBenzinga•Nov 12, 2025, 11:05 AM
Spectral AI Lowers FY2025 Sales Guidance from $21.500M to $18.500M vs $21.507M Est
📉 NegativeBenzinga•Nov 11, 2025, 09:02 PM
Spectral AI Q3 EPS $(0.13) Misses $(0.08) Estimate, Sales $3.792M Miss $5.063M Estimate
📉 NegativeBenzinga•Nov 11, 2025, 09:01 PM
Spectral AI Prices Offering For Issuance Of 4M Shares And Pre-Funded Warrants At $1.90/Share
➖ NeutralBenzinga•Oct 23, 2025, 12:31 PM
Spectral Ai Posts 32% Revenue Drop in Q2
📉 NegativeThe Motley Fool•Aug 13, 2025, 08:19 PM
Frequently Asked Questions about MDAI
What is MDAI's current stock price?
Spectral AI, Inc. (MDAI) is currently trading at $1.55 per share. The stock has moved -1.58% today.
What is the analyst price target for MDAI?
The average analyst price target for MDAI is $3.50, based on 1 analyst.
What sector is Spectral AI, Inc. in?
Spectral AI, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is MDAI's market cap?
Spectral AI, Inc. has a market capitalization of $0.05 billion, making it a small-cap company.
Does MDAI pay dividends?
No, Spectral AI, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCOEP
Coeptis Therapeutics, Inc.
$14.20
Mkt Cap: $0.0B
CTSO
Cytosorbents Corporation
$0.72
Mkt Cap: $0.0B
ECOR
electroCore, Inc.
$6.55
Mkt Cap: $0.1B
EQ
Equillium, Inc.
$1.10
Mkt Cap: $0.0B
ICCM
IceCure Medical Ltd
$0.68
Mkt Cap: $0.0B
IPSC
Century Therapeutics, Inc.
$1.92
Mkt Cap: $0.2B
KPTI
Karyopharm Therapeutics Inc.
$7.93
Mkt Cap: $0.1B
SRTS
Sensus Healthcare, Inc.
$5.13
Mkt Cap: $0.1B
TELA
TELA Bio, Inc.
$1.05
Mkt Cap: $0.0B
TELO
Telomir Pharmaceuticals, Inc. Common Stock
$1.33
Mkt Cap: $0.0B
Explore stocks similar to MDAI for comparison